New York, NY -- (SBWIRE) -- 11/02/2013 -- StockMarketIntel.com issues a special report on the following stocks: Novartis AG (ADR) (NYSE:NVS), Tenet Healthcare Corp (NYSE:THC), Santarus, Inc. (NASDAQ:SNTS), ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)
Novartis AG (ADR) (NYSE:NVS) recently declined -0.39%, while trading on 1.24M shares, at the price of $77.25. The stock changed hands in a range of $76.91 to $77.30 up till now, bringing its market capitalization at about $18812 billion. If we look at its trading history of the past 52 weeks, the share price suffered a low of $58.60 and was moved to the maximum level of $79.54. Novartis AG provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products.
Has NVS Found The Bottom and Ready To Move Up? Find Out Here
Tenet Healthcare Corp (NYSE:THC) while trading on 1.22M shares, at the price of $47.19. The stock changed hands in a range of $46.11 to $47.57 up till now. If we look at its trading history of the past 52 weeks, the share price suffered a low of $23.67 and was moved to the maximum level of $49.47. Tenet Healthcare Corporation (Tenet), along with its subsidiaries, is an investor-owned health care services company. Tenet operates 77 acute care hospitals, 173 outpatient centers, five health plans and six accountable care organizations.
Can Investors Bet on THC after this News update? Find out in this Research Report
Santarus, Inc. (NASDAQ:SNTS) recently added 1.07% and was moving within a range of $23.40 -$23.97. Its current trading price is $23.58. The share price hit its 52-week low of $8.47 and $28.10 was the best price. The stock completed the day with a total volume of 1.23M shares, versus an average volume of 1.80M shares. Santarus, Inc. (Santarus) is a specialty biopharmaceutical company focused on acquiring, developing and commercializing products that address the needs of patients treated by physician specialists.
Will SNTS Continue To Move Higher? Find Out Here
ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) down -0.85% in its current trading activity, bringing its market capitalization around $342.94 million. The total number of shares that changed hands during the current session up till now was 1.21 million shares, as compared to average trading volume of 1.77 million shares. The share price after opening at $3.56 made a high of $3.59 and hovered above $3.50, while its recent trading price was $3.50. ZIOPHARM Oncology, Inc., is a biotechnology company. The Company employs gene expression and control technology to deliver deoxyribonucleic acid (DNA) for the treatment of cancer.
Will ZIOP Get Buyers Even After The Recent Rally? Find Out Here
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)